Kylsans Laboratories Limited

Kylsans Laboratories Ltd . came in existence in the year 1976.

After the year 1984 , business activities of the company were diversified to manufacturing , marketing and exports of pharmaceuticals products only. Presently the company has manufacturing unit, for drugs formulation, at Gohana, Distt Sonepat, Haryana. Within Area of 5000 Sq yards. Having a turn over of 16 Crores.

Kylsans Laboratories Ltd. manufactures and markets branded and generics formulations of international quality. It is equipped with latest and most modern machinery, testing equipments and infrastructure to roll out products as per International Quality Standards. The State Drugs Control Office has issued Good Manufacturing Practice (GMP) Certificate to our company as a measure of appreciation for its quality orientation. Products are manufactured under strict WHO GMP Standards ensuring zero defect products. Excellence in quality is the hallmark of KYLSANS.

 

Production Capacity :

• 8 million Tablets per day.
• 1 million capsules per day.
• 1 million tubes per day.
• .02 million dry syrups per day

Kylsans Laboratories Ltd. is a proactive company and has always laid emphasis on innovation and quality. The company is truly oriented towards Research and Development.

 

Pursuing its mission- “Excellence in Health Care”- Kylsans Laboratories Ltd. has been progressing towards development of products and technology to improve quality of life. Kylsans Laboratories Ltd. has emerged as a leading health care company of India addressing both areas of concern. The company is doing the marketing of own products all over India basis through ethical promotion spanning hospital, nursing home and government institution.

Though the company dominates in institutional/hospitals field.

Some of the prestigeous institutions/Govt. Hospitals/departments/ Ministries of Govt. of India are being illustrated below:

• D.G.S.& D, Ministry of Civil Supplies.
• Directorate General Health Services (DGHS ).
• Armed Forces Medical Store Depot.
• Ministry of Defence.
• Post & Telegraph Dispensaries.
• Central Government Hospital Supply (CGHS) .
• Railways.
• Employee state insurance scheme i.e. ESIS.
• Punjab Health System Corporation.
• State Govts like J&K, Punjab, Himachal Pradesh, Haryana, Rajasthan, Gujarat, Tamil Nadu, Pondicherry, Bihar, Uttarpradesh, Assam, Nagaland, Tripura, West Bengal, NCT of Delhi etc.

Autonomous/ Semi-Autonomous bodies like

• Coal India.
• Geological Survey of India.
• Safdarjang Hospital.
• Dr. Ram Manohar Hospital etc.
• Municipal Corporation of Delhi/New Delhi Municipal Corporation.

 

In short , the company has its presence through out the country i.e. from Andaman Nicobar to J&K, Nepal/Bangladesh/Myanmar border.

To globally present as a healthcare management company.

To establish leadership in all therapeutic area through novel therapies and education.

Our commitment to business development initiatives continues to be a core component of our success as we are expanding both generic and branded business.

Kylsans Laboratories Ltd. has emerged as a leading health care company of India addressing both areas of concern. The endeavour at Kylsans Laboratories Ltd. is to provide value. Value through pioneering work, research & development and quality pharmaceuticals across the globe.

Kylsans keeps alive this endeavour as it steps into the new millennium, and reaffirms its commitment to the environment, the people and a healthier future.

Kylsans Laboratories intends to emerge as an international speciality pharmaceutical company. Currently International markets account for 10% of sales, over the next two years, these are expected to increase to 20% of turnover.

There are two parts to the company's international strategy:

Branded products Generics in Asia and South Africa

Branded products
Branded speciality products that enjoy prescriber confidence in India and have grown to become the mainstay of therapy are marketed internationally. In each of the countries that Kylsans has a presence in, the company uses locally recruited marketing teams and country specific promotional inputs to create a prescription pull and build brands.

Generics in Asia and South Africa
Kylsans Laboratories is building a presence in the high value generic markets in Asia and South Africa. A range of products with increasingly higher value addition, from generics to differentiated generics and branded generics has been identified for introduction.

Company has launched latest molecule Levocetrizine  Dihydrochloride   5mg